Lawsuit alleges Lilly, Novo locked up telehealth to kill compounded GLP-1s Novo Nordisk CEO Mike Doustdar estimated that around 1.5 million US patients are using compounded versions of the company’s drugs. Strive Specialties, one of the largest compounding pharmacies in the country, accused Eli…
Continue reading...